Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KD-CAAP trial of corticosteroids added to IVIG and aspirin in Kawasaki disease
NL-OMON50876Phase 3Completed
- Sponsor
- University College London
- Start
- Jan 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of prednisolone, methylprednisolone, immune globulin, aspirin in Kawasaki disease (KD), sponsored by University College London. Started Jan 2021; status: completed.
02
Drugs
prednisolonemethylprednisoloneimmune globulinaspirin
03
Conditions
Kawasaki disease (KD)
Beyond the preview
Go deeper on NL-OMON50876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50876.